Then, to determine whether CWP232228 treatment affects Wnt/β-catenin signaling in vivo, we investigated the expression patterns of its signaling components, Wnt1, LEF1, and β-catenin in tumor tissues of mice with or without CWP232228 treatment. Here, WNT1 is linked to neoplasm.